Jessica Hagen

Lee Kim, HIMSS senior principal of cybersecurity and privacy, spoke with MobiHealthNews about GPT-5 use in healthcare. She emphasized that patient safety and cybersecurity must remain top priorities for developers.

The acquisition expands Teladoc's specialist network and presence in the region, while the company navigates ongoing financial challenges.

The companies will develop AI models trained on real-world data to help identify and diagnose patients with paroxysmal nocturnal hemoglobinuria.

The company's CEO defended its feature as a wellness tool under the 21st Century Cures Act, combating the FDA’s claim that it qualifies as a regulated medical device.

The feature will be available via new iOS and watchOS updates, one year after the U.S. International Trade Commission banned Apple from selling its Series 9, Series 10 and Ultra 2 watches.

The company will use the funds to expand its technology offerings and nationwide partnerships.

The company will use the funds to open a new headquarters in the Bay Area, scale its reach and platform, and expand its workforce.

The company will use the newly garnered funds to scale its Medical-Grade AI offering.

The company also disclosed that it reached an agreement with most holders of its Series A and Series B warrants to convert those warrants into common stock.

The company says the model excels in healthcare applications, outperforming previous models on real-world clinical tasks and is already being adopted by healthcare companies.